0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Flow Cytometry in Oncology Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-4D6103
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Flow Cytometry in Oncology Market Insights Forecast to 2028
BUY CHAPTERS

Global Flow Cytometry in Oncology Market Research Report 2025

Code: QYRE-Auto-4D6103
Report
June 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Flow Cytometry in Oncology Market

The global market for Flow Cytometry in Oncology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Among the clinical uses of flow cytometry cancer represents one of the most relevant. Several applications of flow cytometry can currently be applied to the study of cancer, including the detection of tumour cell DNA aneuploidy, the analysis of tumour cell proliferation and the immunophenotyping of leukemias.
North American market for Flow Cytometry in Oncology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Flow Cytometry in Oncology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Flow Cytometry in Oncology in Diagnostic Laboratories is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Flow Cytometry in Oncology include Agilent Technologies, Inc., Apogee Flow Systems Ltd., Becton, Dickinson and Company, bioAffinity Technologies, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation Cytek Biosciences, Cytognos, S.L., Danaher Corporation, Miltenyi Biotec B.V. and Co. KG, Laboratory Corporation of America Holdings, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Flow Cytometry in Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flow Cytometry in Oncology.
The Flow Cytometry in Oncology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Flow Cytometry in Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flow Cytometry in Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Flow Cytometry in Oncology Market Report

Report Metric Details
Report Name Flow Cytometry in Oncology Market
Segment by Type
  • Assays and Kits
  • Instruments
  • Reagents and Consumables
  • Software
Segment by Application
  • Diagnostic Laboratories
  • Hospitals and Healthcare Centers
  • Academic and Research Institutions
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Agilent Technologies, Inc., Apogee Flow Systems Ltd., Becton, Dickinson and Company, bioAffinity Technologies, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation Cytek Biosciences, Cytognos, S.L., Danaher Corporation, Miltenyi Biotec B.V. and Co. KG, Laboratory Corporation of America Holdings, Luminex Corporation, NeoGenomics Laboratories, Inc., Sony Corporation, Thermo Fisher Scientific Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Flow Cytometry in Oncology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Flow Cytometry in Oncology Market report?

Ans: The main players in the Flow Cytometry in Oncology Market are Agilent Technologies, Inc., Apogee Flow Systems Ltd., Becton, Dickinson and Company, bioAffinity Technologies, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation Cytek Biosciences, Cytognos, S.L., Danaher Corporation, Miltenyi Biotec B.V. and Co. KG, Laboratory Corporation of America Holdings, Luminex Corporation, NeoGenomics Laboratories, Inc., Sony Corporation, Thermo Fisher Scientific Inc

What are the Application segmentation covered in the Flow Cytometry in Oncology Market report?

Ans: The Applications covered in the Flow Cytometry in Oncology Market report are Diagnostic Laboratories, Hospitals and Healthcare Centers, Academic and Research Institutions, Others

What are the Type segmentation covered in the Flow Cytometry in Oncology Market report?

Ans: The Types covered in the Flow Cytometry in Oncology Market report are Assays and Kits, Instruments, Reagents and Consumables, Software

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Flow Cytometry in Oncology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Assays and Kits
1.2.3 Instruments
1.2.4 Reagents and Consumables
1.2.5 Software
1.3 Market by Application
1.3.1 Global Flow Cytometry in Oncology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals and Healthcare Centers
1.3.4 Academic and Research Institutions
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Flow Cytometry in Oncology Market Perspective (2020-2031)
2.2 Global Flow Cytometry in Oncology Growth Trends by Region
2.2.1 Global Flow Cytometry in Oncology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Flow Cytometry in Oncology Historic Market Size by Region (2020-2025)
2.2.3 Flow Cytometry in Oncology Forecasted Market Size by Region (2026-2031)
2.3 Flow Cytometry in Oncology Market Dynamics
2.3.1 Flow Cytometry in Oncology Industry Trends
2.3.2 Flow Cytometry in Oncology Market Drivers
2.3.3 Flow Cytometry in Oncology Market Challenges
2.3.4 Flow Cytometry in Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Flow Cytometry in Oncology Players by Revenue
3.1.1 Global Top Flow Cytometry in Oncology Players by Revenue (2020-2025)
3.1.2 Global Flow Cytometry in Oncology Revenue Market Share by Players (2020-2025)
3.2 Global Flow Cytometry in Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Flow Cytometry in Oncology Revenue
3.4 Global Flow Cytometry in Oncology Market Concentration Ratio
3.4.1 Global Flow Cytometry in Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Flow Cytometry in Oncology Revenue in 2024
3.5 Global Key Players of Flow Cytometry in Oncology Head office and Area Served
3.6 Global Key Players of Flow Cytometry in Oncology, Product and Application
3.7 Global Key Players of Flow Cytometry in Oncology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Flow Cytometry in Oncology Breakdown Data by Type
4.1 Global Flow Cytometry in Oncology Historic Market Size by Type (2020-2025)
4.2 Global Flow Cytometry in Oncology Forecasted Market Size by Type (2026-2031)
5 Flow Cytometry in Oncology Breakdown Data by Application
5.1 Global Flow Cytometry in Oncology Historic Market Size by Application (2020-2025)
5.2 Global Flow Cytometry in Oncology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Flow Cytometry in Oncology Market Size (2020-2031)
6.2 North America Flow Cytometry in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Flow Cytometry in Oncology Market Size by Country (2020-2025)
6.4 North America Flow Cytometry in Oncology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Flow Cytometry in Oncology Market Size (2020-2031)
7.2 Europe Flow Cytometry in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Flow Cytometry in Oncology Market Size by Country (2020-2025)
7.4 Europe Flow Cytometry in Oncology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Flow Cytometry in Oncology Market Size (2020-2031)
8.2 Asia-Pacific Flow Cytometry in Oncology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Flow Cytometry in Oncology Market Size by Region (2020-2025)
8.4 Asia-Pacific Flow Cytometry in Oncology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Flow Cytometry in Oncology Market Size (2020-2031)
9.2 Latin America Flow Cytometry in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Flow Cytometry in Oncology Market Size by Country (2020-2025)
9.4 Latin America Flow Cytometry in Oncology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Flow Cytometry in Oncology Market Size (2020-2031)
10.2 Middle East & Africa Flow Cytometry in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Flow Cytometry in Oncology Market Size by Country (2020-2025)
10.4 Middle East & Africa Flow Cytometry in Oncology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies, Inc.
11.1.1 Agilent Technologies, Inc. Company Details
11.1.2 Agilent Technologies, Inc. Business Overview
11.1.3 Agilent Technologies, Inc. Flow Cytometry in Oncology Introduction
11.1.4 Agilent Technologies, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.1.5 Agilent Technologies, Inc. Recent Development
11.2 Apogee Flow Systems Ltd.
11.2.1 Apogee Flow Systems Ltd. Company Details
11.2.2 Apogee Flow Systems Ltd. Business Overview
11.2.3 Apogee Flow Systems Ltd. Flow Cytometry in Oncology Introduction
11.2.4 Apogee Flow Systems Ltd. Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.2.5 Apogee Flow Systems Ltd. Recent Development
11.3 Becton, Dickinson and Company
11.3.1 Becton, Dickinson and Company Company Details
11.3.2 Becton, Dickinson and Company Business Overview
11.3.3 Becton, Dickinson and Company Flow Cytometry in Oncology Introduction
11.3.4 Becton, Dickinson and Company Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.3.5 Becton, Dickinson and Company Recent Development
11.4 bioAffinity Technologies, Inc.
11.4.1 bioAffinity Technologies, Inc. Company Details
11.4.2 bioAffinity Technologies, Inc. Business Overview
11.4.3 bioAffinity Technologies, Inc. Flow Cytometry in Oncology Introduction
11.4.4 bioAffinity Technologies, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.4.5 bioAffinity Technologies, Inc. Recent Development
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Bio-Rad Laboratories, Inc. Company Details
11.5.2 Bio-Rad Laboratories, Inc. Business Overview
11.5.3 Bio-Rad Laboratories, Inc. Flow Cytometry in Oncology Introduction
11.5.4 Bio-Rad Laboratories, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.5.5 Bio-Rad Laboratories, Inc. Recent Development
11.6 Bio-Techne Corporation Cytek Biosciences
11.6.1 Bio-Techne Corporation Cytek Biosciences Company Details
11.6.2 Bio-Techne Corporation Cytek Biosciences Business Overview
11.6.3 Bio-Techne Corporation Cytek Biosciences Flow Cytometry in Oncology Introduction
11.6.4 Bio-Techne Corporation Cytek Biosciences Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.6.5 Bio-Techne Corporation Cytek Biosciences Recent Development
11.7 Cytognos, S.L.
11.7.1 Cytognos, S.L. Company Details
11.7.2 Cytognos, S.L. Business Overview
11.7.3 Cytognos, S.L. Flow Cytometry in Oncology Introduction
11.7.4 Cytognos, S.L. Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.7.5 Cytognos, S.L. Recent Development
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Details
11.8.2 Danaher Corporation Business Overview
11.8.3 Danaher Corporation Flow Cytometry in Oncology Introduction
11.8.4 Danaher Corporation Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.8.5 Danaher Corporation Recent Development
11.9 Miltenyi Biotec B.V. and Co. KG
11.9.1 Miltenyi Biotec B.V. and Co. KG Company Details
11.9.2 Miltenyi Biotec B.V. and Co. KG Business Overview
11.9.3 Miltenyi Biotec B.V. and Co. KG Flow Cytometry in Oncology Introduction
11.9.4 Miltenyi Biotec B.V. and Co. KG Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.9.5 Miltenyi Biotec B.V. and Co. KG Recent Development
11.10 Laboratory Corporation of America Holdings
11.10.1 Laboratory Corporation of America Holdings Company Details
11.10.2 Laboratory Corporation of America Holdings Business Overview
11.10.3 Laboratory Corporation of America Holdings Flow Cytometry in Oncology Introduction
11.10.4 Laboratory Corporation of America Holdings Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.10.5 Laboratory Corporation of America Holdings Recent Development
11.11 Luminex Corporation
11.11.1 Luminex Corporation Company Details
11.11.2 Luminex Corporation Business Overview
11.11.3 Luminex Corporation Flow Cytometry in Oncology Introduction
11.11.4 Luminex Corporation Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.11.5 Luminex Corporation Recent Development
11.12 NeoGenomics Laboratories, Inc.
11.12.1 NeoGenomics Laboratories, Inc. Company Details
11.12.2 NeoGenomics Laboratories, Inc. Business Overview
11.12.3 NeoGenomics Laboratories, Inc. Flow Cytometry in Oncology Introduction
11.12.4 NeoGenomics Laboratories, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.12.5 NeoGenomics Laboratories, Inc. Recent Development
11.13 Sony Corporation
11.13.1 Sony Corporation Company Details
11.13.2 Sony Corporation Business Overview
11.13.3 Sony Corporation Flow Cytometry in Oncology Introduction
11.13.4 Sony Corporation Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.13.5 Sony Corporation Recent Development
11.14 Thermo Fisher Scientific Inc
11.14.1 Thermo Fisher Scientific Inc Company Details
11.14.2 Thermo Fisher Scientific Inc Business Overview
11.14.3 Thermo Fisher Scientific Inc Flow Cytometry in Oncology Introduction
11.14.4 Thermo Fisher Scientific Inc Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.14.5 Thermo Fisher Scientific Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Flow Cytometry in Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Assays and Kits
 Table 3. Key Players of Instruments
 Table 4. Key Players of Reagents and Consumables
 Table 5. Key Players of Software
 Table 6. Global Flow Cytometry in Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Flow Cytometry in Oncology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Flow Cytometry in Oncology Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Flow Cytometry in Oncology Market Share by Region (2020-2025)
 Table 10. Global Flow Cytometry in Oncology Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Flow Cytometry in Oncology Market Share by Region (2026-2031)
 Table 12. Flow Cytometry in Oncology Market Trends
 Table 13. Flow Cytometry in Oncology Market Drivers
 Table 14. Flow Cytometry in Oncology Market Challenges
 Table 15. Flow Cytometry in Oncology Market Restraints
 Table 16. Global Flow Cytometry in Oncology Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Flow Cytometry in Oncology Market Share by Players (2020-2025)
 Table 18. Global Top Flow Cytometry in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flow Cytometry in Oncology as of 2024)
 Table 19. Ranking of Global Top Flow Cytometry in Oncology Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Flow Cytometry in Oncology Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Flow Cytometry in Oncology, Headquarters and Area Served
 Table 22. Global Key Players of Flow Cytometry in Oncology, Product and Application
 Table 23. Global Key Players of Flow Cytometry in Oncology, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Flow Cytometry in Oncology Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Flow Cytometry in Oncology Revenue Market Share by Type (2020-2025)
 Table 27. Global Flow Cytometry in Oncology Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Flow Cytometry in Oncology Revenue Market Share by Type (2026-2031)
 Table 29. Global Flow Cytometry in Oncology Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Flow Cytometry in Oncology Revenue Market Share by Application (2020-2025)
 Table 31. Global Flow Cytometry in Oncology Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Flow Cytometry in Oncology Revenue Market Share by Application (2026-2031)
 Table 33. North America Flow Cytometry in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Flow Cytometry in Oncology Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Flow Cytometry in Oncology Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Flow Cytometry in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Flow Cytometry in Oncology Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Flow Cytometry in Oncology Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Flow Cytometry in Oncology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Flow Cytometry in Oncology Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Flow Cytometry in Oncology Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Flow Cytometry in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Flow Cytometry in Oncology Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Flow Cytometry in Oncology Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Flow Cytometry in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Flow Cytometry in Oncology Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Flow Cytometry in Oncology Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Agilent Technologies, Inc. Company Details
 Table 49. Agilent Technologies, Inc. Business Overview
 Table 50. Agilent Technologies, Inc. Flow Cytometry in Oncology Product
 Table 51. Agilent Technologies, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
 Table 52. Agilent Technologies, Inc. Recent Development
 Table 53. Apogee Flow Systems Ltd. Company Details
 Table 54. Apogee Flow Systems Ltd. Business Overview
 Table 55. Apogee Flow Systems Ltd. Flow Cytometry in Oncology Product
 Table 56. Apogee Flow Systems Ltd. Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
 Table 57. Apogee Flow Systems Ltd. Recent Development
 Table 58. Becton, Dickinson and Company Company Details
 Table 59. Becton, Dickinson and Company Business Overview
 Table 60. Becton, Dickinson and Company Flow Cytometry in Oncology Product
 Table 61. Becton, Dickinson and Company Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
 Table 62. Becton, Dickinson and Company Recent Development
 Table 63. bioAffinity Technologies, Inc. Company Details
 Table 64. bioAffinity Technologies, Inc. Business Overview
 Table 65. bioAffinity Technologies, Inc. Flow Cytometry in Oncology Product
 Table 66. bioAffinity Technologies, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
 Table 67. bioAffinity Technologies, Inc. Recent Development
 Table 68. Bio-Rad Laboratories, Inc. Company Details
 Table 69. Bio-Rad Laboratories, Inc. Business Overview
 Table 70. Bio-Rad Laboratories, Inc. Flow Cytometry in Oncology Product
 Table 71. Bio-Rad Laboratories, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
 Table 72. Bio-Rad Laboratories, Inc. Recent Development
 Table 73. Bio-Techne Corporation Cytek Biosciences Company Details
 Table 74. Bio-Techne Corporation Cytek Biosciences Business Overview
 Table 75. Bio-Techne Corporation Cytek Biosciences Flow Cytometry in Oncology Product
 Table 76. Bio-Techne Corporation Cytek Biosciences Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
 Table 77. Bio-Techne Corporation Cytek Biosciences Recent Development
 Table 78. Cytognos, S.L. Company Details
 Table 79. Cytognos, S.L. Business Overview
 Table 80. Cytognos, S.L. Flow Cytometry in Oncology Product
 Table 81. Cytognos, S.L. Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
 Table 82. Cytognos, S.L. Recent Development
 Table 83. Danaher Corporation Company Details
 Table 84. Danaher Corporation Business Overview
 Table 85. Danaher Corporation Flow Cytometry in Oncology Product
 Table 86. Danaher Corporation Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
 Table 87. Danaher Corporation Recent Development
 Table 88. Miltenyi Biotec B.V. and Co. KG Company Details
 Table 89. Miltenyi Biotec B.V. and Co. KG Business Overview
 Table 90. Miltenyi Biotec B.V. and Co. KG Flow Cytometry in Oncology Product
 Table 91. Miltenyi Biotec B.V. and Co. KG Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
 Table 92. Miltenyi Biotec B.V. and Co. KG Recent Development
 Table 93. Laboratory Corporation of America Holdings Company Details
 Table 94. Laboratory Corporation of America Holdings Business Overview
 Table 95. Laboratory Corporation of America Holdings Flow Cytometry in Oncology Product
 Table 96. Laboratory Corporation of America Holdings Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
 Table 97. Laboratory Corporation of America Holdings Recent Development
 Table 98. Luminex Corporation Company Details
 Table 99. Luminex Corporation Business Overview
 Table 100. Luminex Corporation Flow Cytometry in Oncology Product
 Table 101. Luminex Corporation Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
 Table 102. Luminex Corporation Recent Development
 Table 103. NeoGenomics Laboratories, Inc. Company Details
 Table 104. NeoGenomics Laboratories, Inc. Business Overview
 Table 105. NeoGenomics Laboratories, Inc. Flow Cytometry in Oncology Product
 Table 106. NeoGenomics Laboratories, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
 Table 107. NeoGenomics Laboratories, Inc. Recent Development
 Table 108. Sony Corporation Company Details
 Table 109. Sony Corporation Business Overview
 Table 110. Sony Corporation Flow Cytometry in Oncology Product
 Table 111. Sony Corporation Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
 Table 112. Sony Corporation Recent Development
 Table 113. Thermo Fisher Scientific Inc Company Details
 Table 114. Thermo Fisher Scientific Inc Business Overview
 Table 115. Thermo Fisher Scientific Inc Flow Cytometry in Oncology Product
 Table 116. Thermo Fisher Scientific Inc Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
 Table 117. Thermo Fisher Scientific Inc Recent Development
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Flow Cytometry in Oncology Picture
 Figure 2. Global Flow Cytometry in Oncology Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Flow Cytometry in Oncology Market Share by Type: 2024 VS 2031
 Figure 4. Assays and Kits Features
 Figure 5. Instruments Features
 Figure 6. Reagents and Consumables Features
 Figure 7. Software Features
 Figure 8. Global Flow Cytometry in Oncology Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Flow Cytometry in Oncology Market Share by Application: 2024 VS 2031
 Figure 10. Diagnostic Laboratories Case Studies
 Figure 11. Hospitals and Healthcare Centers Case Studies
 Figure 12. Academic and Research Institutions Case Studies
 Figure 13. Others Case Studies
 Figure 14. Flow Cytometry in Oncology Report Years Considered
 Figure 15. Global Flow Cytometry in Oncology Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Flow Cytometry in Oncology Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Flow Cytometry in Oncology Market Share by Region: 2024 VS 2031
 Figure 18. Global Flow Cytometry in Oncology Market Share by Players in 2024
 Figure 19. Global Top Flow Cytometry in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flow Cytometry in Oncology as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Flow Cytometry in Oncology Revenue in 2024
 Figure 21. North America Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Flow Cytometry in Oncology Market Share by Country (2020-2031)
 Figure 23. United States Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Flow Cytometry in Oncology Market Share by Country (2020-2031)
 Figure 27. Germany Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Flow Cytometry in Oncology Market Share by Region (2020-2031)
 Figure 35. China Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Flow Cytometry in Oncology Market Share by Country (2020-2031)
 Figure 43. Mexico Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Flow Cytometry in Oncology Market Share by Country (2020-2031)
 Figure 47. Turkey Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Agilent Technologies, Inc. Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
 Figure 51. Apogee Flow Systems Ltd. Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
 Figure 52. Becton, Dickinson and Company Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
 Figure 53. bioAffinity Technologies, Inc. Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
 Figure 54. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
 Figure 55. Bio-Techne Corporation Cytek Biosciences Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
 Figure 56. Cytognos, S.L. Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
 Figure 57. Danaher Corporation Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
 Figure 58. Miltenyi Biotec B.V. and Co. KG Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
 Figure 59. Laboratory Corporation of America Holdings Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
 Figure 60. Luminex Corporation Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
 Figure 61. NeoGenomics Laboratories, Inc. Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
 Figure 62. Sony Corporation Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
 Figure 63. Thermo Fisher Scientific Inc Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools